Structure and function of midkine, a novel heparin-binding growth factor;Budowa i funkcja midkiny, nowego czynnika wzrostu wiązącego heparynę

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 591-601

  Krzystek Korpacka, Małgorzata ^a   Matusiewicz, Małgorzata ^a   Banas̈, Teresa ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Angiogenesis; Cytokine; Differentiation; Growth factor; Midkine; Neurokine; Organogenesis; Retinoic acid

Indexed keywords

CYTOKINE; GROWTH FACTOR RECEPTOR; GROWTH PROMOTOR; MEMBRANE PROTEIN; MIDKINE; SCLEROPROTEIN;

ANGIOGENESIS; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; GROWTH SUBSTANCES; HUMANS; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, GROWTH FACTOR;

EID: 39049177054     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Akhter S., Ichihara-Tanaka K., Kojima S., Muramatsu H., Inui T., Kimura T., Kaneda N., Talukder A.H., Kadomatsu K., Inagaki F., Muramatsu T.: Clusters of basic amino acids in midkine: roles in neurite-promoting activity and plasminogen activator-enhancing activity. J. Biochem., 1998; 123: 1127-1136
2. Asai T., Watanabe K., Ichihara-Tanaka K., Kaneda N., Kojima S., Iguchi A., Inagaki F., Muramatsu T.: Identification of heparin-binding sites in midkine and their role in neurite-promotion. Biochem. Biophys. Res. Commun., 1997; 236: 66-70
3. Bandtlow C.E., Zimmermann D.R.: Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev., 2000; 80: 1267-1290
4. Bao X., Nishimura S., Mikami T., Yamada S., Itoh N., Sugahara K.: Chondroitin sulfate/dermatan sulfate hybrid chains from embryonic pig brain, which contain a higher proportion of L-iduronic acid then those from adult pig brain, exhibit neuritogenic and growth factor binding activities. J. Biol. Chem., 2004; 279: 9765-9776
5. Boorjian S., Scherr D.S., Mongan N.P., Zhuang Y., Nanus D.M., Gudas L.J.: Retinoid receptor mRNA expression profiles in human bladder cancer specimens. Int. J. Oncol., 2005; 26: 1041-1048
6. Callebaut C., Nisole S., Briand J.P., Krust B., Hovanessian A.G.: Inhibition of HIV infection by the cytokine midkine. Virology, 2001; 281: 248-264
7. Chen Q., Yuan Y., Lin S., Chang Y., Zhuo X., Wei W., Tao P., Ruan L., Li Q., Li Z.: Transiently truncated and differentially regulated expression of midkine during mouse embryogenesis. Biochem. Biophys. Res. Commun., 2005; 330: 1230-1236
8. Clement A.M., Sugahara K., Faissner A.: Chondroitin sulfate E promotes neurite outgrowth of rat embryonic day 18 hippocampal neurons. Neurosci. Lett., 1999; 269: 125-128
9. Dai L., Xu D., Yao X., Lu Y., Xu Z.: Conformational determinants of the intracellular localization of midkine. Biochem. Biophys. Res. Commun., 2005; 330: 310-317
10. Deepa S.S., Yamada S., Zako M., Goldberger O., Sugahara K.: Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. J. Biol. Chem., 2004; 279: 37368-37376
11. Fabri L., Maruta H., Muramatsu H., Muramatsu T., Simpson R.J., Burgess A.W., Nice E.C.: Structural characterization of native and recombinant forms of the neurotrophic cytokine MK. J. Chromatogr., 1993; 646: 213-225
12. Harvey B.K., Shen H., Chen G.-J., Yoshida Y., Wang Y.: Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats. Neurosci. Lett., 2004; 369: 138-141
13. Hayashi K., Kadomatsu K., Muramatsu T.: Requirement of chondroitin sulfate/dermatan sulfate recognition in midkine-dependent migration of macrophages. Glycoconj. J., 2001; 18: 401-406
14. Herradon G., Ezquerra L., Nguyen T., Silos-Santiago I., Deuel T.F.: Midkine regulates pleiotrophin organ-specific gene expression: Evidence for transcriptional regulation and functional redundancy within the pleiotrophin/midkine developmental gene family. Biochem. Biophys. Res. Commun., 2005; 333: 714-721
15. Hirota Y., Osuga Y., Koga K., Yoshino O., Hirata T., Harada M., Morimoto C., Yano T., Tsutsumi O., Sakuma S., Muramatsu T., Taketani Y.: Possible implication of midkine in the development of endometriosis. Hum. Reprod., 2005; 20: 1084-1089
16. Horiba M., Kadomatsu K., Nakamura E., Muramatsu H., Ikematsu S., Sakuma S., Hayashi K., Yuzawa Y., Matsuo S., Kuzuya M., Kaname T., Hirai M., Saito H., Muramatsu T.: Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J. Clin. Invest., 2000; 105: 489-495
17. Hu J., Higuchi I., Yoshida Y., Shiraishi T., Osame M.: Expression of midkine in regenerating skeletal muscle fibres and cultured myoblasts of human skeletal muscle. Eur. Neurol., 2002; 47: 20-25
18. Ikeda S., Ichihara-Tanaka K., Azuma T., Muramatsu T., Yamada M.: Effects of midkine during in vitro maturation of bovine oocytes on subsequent developmental competence. Biol. Reprod., 2000; 63: 1067-1074
19. Ikeda S., Kitagawa M., Imai H., Yamada M.: The roles of Vitamin A for cytoplasmic maturation of bovine oocytes. J. Reprod. Dev., 2005; 51: 23-35
20. Inazumi T., Tajima S., Nishikawa T., Kadomatsu K., Muramatsu H., Muramatsu T.: Expression of the retinoid-inducible polypeptide, midkine, in human epidermal keratinocytes. Arch. Dermatol. Res., 1997; 289: 471-475
21. Iwasaki W., Nagata K., Hatanaka H., Inui T., Kimura T., Muramatsu T., Yoshida K., Tasumi M., Inagaki F.: Solution structure of midkine, a new heparin-binding growth factor. EMBO J., 1997; 16: 6936-6946
22. Iwashita N., Muramatsu H., Toriyama K., Torii S., Muramatsu T.: Expression of midkine in normal and burn sites of rat skin. Burns, 1999; 25: 119-124
23. Jia X.Q., Nakashima T., Kadomatsu K., Muramatsu T.: Expression of midkine in the cochlea. Hear. Res., 2001; 160: 10-14
24. Joo E.J., ten Dam G.B., van Kuppevelt T.H., Toida T., Linhardt R.J., Kim Y.S.: Nucleolin: acharan sulfate-binding protein on the surface of cancer cells. Glycobiology, 2005; 15: 1-9
25. Kadomatsu K., Huang R. P., Suganuma T., Murata F., Muramatsu T.: A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J. Cell Biol., 1990; 110: 607-616
26. Kadomatsu K., Muramatsu T.: Midkine and pleiotrophin in neural development and cancer. Cancer Lett., 2004; 204: 127-143
27. Kadomatsu K., Tomomura M., Muramatsu T.: cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem. Biophys. Res. Commun., 1988; 151: 1312-1318
28. Kaname T., Kadomatsu K., Aridome K., Yamashita S., Sakamoto K., Ogawa M., Muramatsu T., Yamamura K.: The expression of truncated MK in human tumors. Biochem. Biophys. Res. Commun., 1996; 219: 256-260
29. Kaneda N., Talukder A.H., Ishihara M., Hara S., Yoshida K., Muramatsu T.: Structural characteristics of heparin-like domain required for interaction of midkine with embryonic neurons. Biochem. Biophys. Res. Commun., 1996; 220: 108-112
30. Kaneda N., Talukder A.H., Nishiyama H., Koizumi S., Muramatsu T.: Midkine, a heparin-binding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro. J. Biochem., 1996; 119: 1150-1156
31. Kaplan F., Comber J., Sladek R., Hudson T.J., Muglia L.J., Macrae T., Gagnon S., Asada M., Brewer J.A., Sweezey N.B.: The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development. Am. J. Respir. Cell Mol. Biol., 2003; 28: 33-41
32. Kato M., Maeta H., Kato S., Shinozawa T., Terada T.: Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma. Mod. Pathol., 2000; 13: 1060-1065
33. Kato S., Shinozawa T., Takikawa M., Kato M., Hirano A., Awaya A., Ohama E.: Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains. Acta Neuropathol., 2000; 100: 481-489
34. Kikuchi-Horie K., Kawakami E., Kamata M., Wada M., Hu J.G., Nakagawa H., Ohara K., Watabe K., Oyanagi K.: Distinctive expression of midkine in the repair period of rat brain during neurogenesis. Immunohistochemical and immunoelectron microscopic observations. J.Neurosci. Res., 2004; 75: 678-687
35. Kinnunen T., Kaksonen M., Saarinen J., Kalkkinen N., Peng H.B., Rauvala H.: Cortactin-Src kinase signaling pathway is involved in Nsyndecan-dependent neurite outgrowth. J. Biol. Chem., 1998; 273: 10702-10708
36. Kojima S., Inui T., Muramatsu H., Kimura T., Sakakibara S., Muramatsu T.: Midkine is a heat and acid stable polypeptide capable of enhancing plasminogen activator activity and neurite outgrowth extension. Bioch. Biophys. Res. Commun., 1995; 216: 574-581
37. Kojima T., Katsumi A., Yamazaki T., Muramatsu T., Nagasaka T., Ohsumi K., Saito H.: Human ryudocan from endothelial-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor. J. Biol. Chem., 1996; 271: 5914-5920
38. Kojima S., Muramatsu H., Amanuma H., Muramatsu T.: Midkine enhances fibrinolytic activity of bovine endothelial cells. J. Biol. Chem., 1995; 270: 9590-9596
39. Koshizawa S.H., Matsumura T., Kadono Y., Sawada T., Kadomatsu K., Muramatsu H., Muramatsu T.: Alteration of midkine expression associated with chemically-induced differentiation in human neuroblastoma cells. Cancer Lett., 1997; 111: 117-125
40. Kurosawa N., Chen G., Kadomatsu K., Ikematsu S., Sakuma S., Muramatsu T.: Glypican-2 binds to midkine: The role of glypican-2 in neuronal cell adhesion and neurite outgrowth. Glycoconj. J., 2001; 18: 499-507
41. Li Y.S., Milner P.G., Chauhan A.K., Watson M.A., Hoffman R.M., Kodner C.M., Milbrandt J., Deuel T.F.: Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science, 1990; 250: 1690-1694
42. Lie-A-Ling M., Bakker C.T., Deurholt T., Hoekstra R., Wesseling J.G., Afford S.C., Bosma P.J.: Selection of tumor specific promoters for adenoviral gene therapy of cholangiocarcinoma. J. Hepathol., 2006; 44: 126-133
43. Lillis A.P., Mikhailenko I., Strickland D.K.: Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J. Thromb. Haemost., 2005; 3: 1884-1893
44. Maeda N., Ichihara-Tanaka K., Kimura T., Kadomatsu K., Muramatsu T., Noda M.: A receptor-like protein-tyrosine phosphatase PTPz/RPTPb binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPz. J. Biol. Chem., 1999; 274: 12474-12479
45. Maekawa T., Waki S., Okada A., Fukui H., Kinoshita Y., Chiba T.: Midkine gene expression in the healing process of gastric ulcer. J. Lab. Clin. Med., 1999; 133: 349-352
46. Mahoney S.-A., Perry M., Seddon A., Bohlen P., Haynes L.: Transglutaminase forms midkine homodimers in cerebellar neurons and modulates the neurite-outgrowth response. Biochem. Biophys. Res. Commun., 1996; 224: 147-152
47. Mahoney S.-A., Wilkinson M., Smith S., Haynes L.W.: Stabilization of neurites in cerebellar granule cells by transglutaminase activity: identification of midkine and galectin-3 as substrates. Neuroscience, 2000; 101: 141-155
48. Maruyama K., Muramatsu H., Ishiguro N., Muramatsu T.: Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. Arthritis Rheum., 2004; 50: 1420-1429
49. Mashour G.A., Ratner N., Khan G.A., Wang H.L., Martuza R.L., Kurtz A.: The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Oncogene, 2001; 20: 97-105
50. Matsuura O., Kadomatsu K., Takei Y., Uchimura K., Mimura S., Watanabe K., Muramatsu T.: Midkine expression is associated with postnatal development of the lungs. Cell Struct. Funct., 2002; 27: 109-115
51. Mirkin B.L., Clark S., Zheng X., Chu F., White B.D., Green M., Rebbaa A.: Identification of midkine as a mediator for intracellular transfer of drug resistance. Oncogene, 2005; 24: 4965-4974
52. Mitsiadis T.A., Muramatsu T., Muramatsu H., Thesleff I.: Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J. Cell Biol., 1995; 129: 267-281
53. Mochizuki R., Takeda A., Sato N., Kimpara T., Onodera H., Itoyama Y., Muramatsu T.: Induction of midkine expression in reactive astrocytes following rat transcient forebrain ischemia. Exp. Neurol., 1998; 149: 73-78
54. Monji A., Yoshida I., Tashiro K., Hayashi Y., Matsuda K., Tashiro N.: Inhibition of Ab fibril formation and Ab-induced cytotoxicity by senile plaque-associated proteins. Neurosci. Lett., 2000; 278: 81-84
55. Muramatsu H., Inui T., Kimura T., Sakakibara S., Song X.J., Maruta H., Muramatsu T.: Localization of heparin-binding, neurite outgrowth and antigenic regions in midkine molecule. Biochem. Biophys. Res. Commun., 1994; 203: 1131-1139
56. Muramatsu H., Muramatsu T.: Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem. Biophys. Res. Commun., 1991; 177: 652-658
57. Muramatsu H., Zou K., Sakaguchi N., Ikematsu S., Sakuma S., Muramatsu T.: LDL-receptor related protein as a component of the midkine receptor. Biochem. Biophys. Res. Commun., 2000; 270: 936-941
58. Muramatsu H., Zou P., Suzuki H., Oda Y., Chen G.-Y., Sakaguchi N., Sakuma S., Maeda N., Noda M., Takada Y., Muramatsu T.: a4b1-and a6b1-integrins are functional receptors for midkine, a heparin-binding growth factor. J. Cell Sci., 2004; 117: 5405-5415
59. Muramatsu T.: Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem., 2002; 132: 359-371
60. Nakanishi T., Kadomatsu K., Okamoto T., Ichihara-Tanaka K., Kojima T., Saito H., Tomoda Y., Muramatsu T.: Expression of syndecan-1 and-3 during embryogenesis of the central nervous system in relation to binding with midkine. J. Biochem., 1997; 121: 197-205
61. Nurcombe V., Fraser N., Herlaar E., Heath J.K.: MK: A pluripotential embryonic stem-cell-derived neuroregulatory factor. Development, 1992; 116: 1175-1183
62. Ochiai K., Muramatsu H., Yamamoto S., Ando H., Muramatsu T.: The role of midkine and pleiotrophin in liver regeneration. Liver Int., 2004; 24: 484-491
63. Ohta S., Muramatsu H., Senda T., Zou K., Iwata H., Muramatsu T.: Midkine is expressed during repair of bone fracture and promotes chondrogenesis. J. Bone Miner. Res., 1999; 14: 1132-1144
64. Ohuchida T., Okamoto K., Akahane K., Higure A., Todoroki H., Abe Y., Kikuchi M., Ikematsu S., Muramatsu T., Itoh H.: Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity. Cancer, 2004; 100: 2430-2436
65. Owada K., Sanjo N., Kobayashi T., Mizusawa H., Muramatsu H., Muramatsu T., Michikawa M.: Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J. Neurochem., 1999; 73: 2084-2092
66. Owada K., Sanjyo N., Kobayashi T., Kamata T., Mizusawa H., Muramatsu H., Muramatsu T., Michikawa M.: Midkine inhibits apoptosis via extracellular signal regulated kinase (ERK) activation in PC12 cells. J. Med. Dent. Sci., 1999; 46: 45-51
67. Paul S., Mitsumoto T., Yamamoto I., Shinozawa T.: Molecular cloning, expression and purification of truncated midkine and its growth stimulatory activity on Wilms' tumor (G401) cells. Cancer Lett., 2001; 163: 239-244
68. Pedraza C., Matsubara S., Muramatsu T.: A retinoic acid-responsive element in human midkine gene. J. Biochem., 1995; 117: 845-849
69. Pepper M.S., Sappino A.P., Stocklin R., Montesano R., Orci L., Vassalli J.D.: Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol., 1993; 122: 673-684
70. Piscione T.D., Rosenblum N.D.: The molecular control of renal branching morphogenesis: current knowledge and emerging insights. Differentiation, 2002; 70: 227-246
71. Qi M., Ikematsu S., Ichihara-Tanaka K., Sakuma S., Muramatsu T., Kadomatsu K.: Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by midkine. J. Biochem., 2000; 127: 269-277
72. Qi M., Ikematsu S., Maeda N., Ichihara-Tanaka K., Sakuma S., Noda M., Muramatsu T., Kadomatsu K.: Haptotactic migration induced by midkine: Involvement of protein-tyrosine phosphatase z, mitogen-activated protein kinase and phosphatidylinositol 3-kinase. J. Biol. Chem., 2001; 276: 15868-15875
73. Ratovitski E.A., Kotzbauer P.T., Milbrandt J., Lowenstein C.J., Burrow C.R.: Midkine induces tumor cell proliferation and binds to a high affinity signaling receptor associated with JAK tyrosine kinases. J. Biol. Chem., 1998; 273: 3654-3660
74. Rawlings J.S., Rosler K.M., Harrison D.A.: The JAK/STAT signaling pathway. J. Cell Sci., 2004; 117: 1281-1283
75. Rebbaa A., Chou P.M., Mirkin B.L.: Factors secreted by human neuroblastoma mediated doxorubicin resistance by activating STAT3 and inhibiting apoptosis. Mol. Med., 2001; 7: 393-400
76. Reynolds P.R., Mucenski M.L., Le Cras T.D., Nichols W.C., Whitsett J.A.: Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J. Biol. Chem., 2004; 279: 37124-37132
77. Roszkowski K., Ziólkowska E.: Fibrynoliza w procesie nowotworowym. Wspólczesna Onkologia Polska, 2005; 9: 196-198
78. Rumsby M., Ichohara-Tanaka K., Kimura T., Scott M., Haynes L., Muramatsu T.: Bipolar undifferentiated CG-4 oligodendroglial line cells adhere, extend processes and disperse on midkine, a heparinbinding growth factor: orthovanadate and chondroitin sulphate E inhibit cell attachment. Neurosci. Res. Commun., 2001; 28: 31-39
79. Said E.A., Krust B., Nisole S., Svab J., Briand J.P., Hovanessian A.G.: The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor. J. Biol. Chem., 2002; 277: 37492-37502
80. Sakaguchi N., Muramatsu H., Ichihara-Tanaka K., Maeda N., Noda M., Yamamoto T., Michikawa M., Ikematsu S., Sakuma S., Muramatsu T.: Receptor-type protein tyrosine phosphatase z as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons. Neurosci. Res., 2003; 45: 219-224
81. Sakakima H., Yashida Y., Kadomatsu K., Yuzawa Y., Matsuo S., Muramatsu T.: Midkine expression in rat spinal motor neurons following sciatic nerve injury. Dev. Brain Res., 2004; 153: 251-260
82. Salama R.H.M., Muramatsu H., Shimizu E., Hashimoto K., Ohgake S., Watanabe H., Komatsu N., Okamura N., Koike K., Shinoda N., Okada S., Iyo M., Muramatsu T.: Increased midkine levels in sera from patients with Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2005; 29: 611-616
83. Salama R.H., Muramatsu H., Zou K., Inui T., Kimura T., Muramatsu T.: Midkine binds to 37-kDa laminin-binding protein precursor, leading to nuclear transport of the complex. Exp. Cell Res., 2001; 270: 13-20
84. Sandra F., Harada H., Nakamura N., Ohishi M.: Midkine induced growth of ameloblastoma through MAPK and Akt pathways. Oral Oncol., 2004; 40: 274-280
85. Sato W., Kadomatsu K., Yuzawa Y., Muramatsu H., Hotta N., Matsuo S., Muramatsu T.: Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J. Immunol., 2001; 167: 3463-3469
86. Shibata Y., Muramatsu T., Hirai M., Inui T., Kimura T., Saito H., McCormick L.M., Bu G., Kadomatsu K.: Nuclear targeting by the growth factor midkine. Mol. Cell. Biol., 2002; 22: 6788-6796
87. Smith F.I., Qu U., Hang S.J., Kim K.S., Gilmartin T.J., Head S.R.: Gene expression profiling of mouse postnatal cerebellar development using oligonucleotide microarrays designed to detect differences in glycoconjugate expression. Gene Expr. Patterns, 2005; 5: 740-749
88. Stoica G.E., Kuo A., Powers C., Bowden E.T., Sale E.B., Riegel A.T., Wellstein A.: Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J. Biol. Chem., 2002; 277: 35990-35998
89. Sumi Y., Muramatsu H., Hata K., Ueda M., Muramatsu T.: Midkine enhances early stages of collagen gel contraction. J. Biochem., 2000; 127: 247-251
90. Sumi Y., Muramatsu H., Takei Y., Hata K., Ueda M., Muramatsu T.: Midkine, a heparin-binding growth factor promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model. J. Cell Sci., 2002; 115: 2659-2667
91. Suzuki N., Shibata Y., Urano T., Murohara T., Muramatsu T., Kadomatsu K.: Proteasomal degradation of the nuclear targeting growth factor midkine. J. Biol. Chem., 2004; 279: 17785-17791
92. Takada J., Ooboshi H., Ago T., Kitazono T., Yao H., Kadomatsu K., Muramatsu T., Ibayashi S., Iida M.: Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther., 2005; 12: 487-493
93. Takada T., Toriyama K., Muramatsu H., Song X.J., Torii S., Muramatsu T.: Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J. Biochem., 1997; 122: 453-458
94. Take M., Tsutsui J., Obama H., Ozawa M., Nakayama T., Maruyama I., Arima T., Muramatsu T.: Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth-associated molecule (HB-GAM). J. Biochem., 1994; 116: 1063-1068
95. Tomomura M., Kadomatsu K., Matsubara S., Muramatsu T.: A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J. Biol. Chem., 1990; 265: 10765-10770
96. Tomomura M., Kadomatsu K., Nakamoto M., Muramatsu H., Kondoh H., Imagawa K., Muramatsu T.: A retinoic acid responsive gene, MK, produces a secreted protein with heparin binding activity. Biochem. Biophys. Res. Commun., 1990; 171: 603-609
97. Toriyama K., Muramatsu H., Hoshino T., Torii S., Muramatsu T.: Evaluation of heparin-binding growth factors in rescuing morphogenesis of heparitinase-treated mouse embryonic lung explants. Differentiation, 1997; 61: 161-167
98. Tsuchida K., Shioi J., Yamada S., Boghosian G., Wu A., Cai H., Sugahara K., Robakis N.K.: Appican, the proteoglycan form of the amyloid precursor protein, contains chondroitin sulfate E in the repeating disaccharide region and 4-O-sulfated galactose in the linkage region. J. Biol. Chem., 2001; 276: 37155-37160
99. Tsutsui J., Uehara K., Kadomatsu K., Matsubara S., Muramatsu T.: A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem. Biophys. Res. Commun., 1991; 176: 792-797
100. Uehara K., Matsubara S., Kadomatsu K., Tsutsui J., Muramatsu T.: Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. J. Biochem., 1992; 111: 563-567
101. Ueoka C., Kaneda N., Okazaki I., Nadanaka S., Muramatsu T., Sugahara K.: Neuronal cell adhesion mediated by the heparin-binding neuroregulatory factor, midkine, is specifically inhibited by chondroitin sulfate E. Structural and functional implication of the oversulfated chondroitin sulfate. J. Biol. Chem., 2000; 275: 37407-37413
102. Umehara Y., Yamada S., Nishimura S., Shioi J., Robakis N.K., Sugahara K.: Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin-binding neuroregulatory factors. FEBS Lett., 2004; 557: 233-238
103. Vilar J., Lalou C., van Huyen J.-P.D., Charrin S., Hardouin S., Raulais D., Merlet-Benichou C., Lelievre-Pegorier M.: Midkine is involved in kidney development and its regulation by retinoids. J. Am. Soc. Nephrol., 2002; 13: 668-676
104. Wada M., Kamata M., Aizu Y., Morita T., Hu J., Oyanagi K.: Alteration of midkine expression in the ischemic brain of humans. J. Neurol. Sci., 2002; 200: 67-73
105. Yamada H., Inazumi T., Tajima S., Muramatsu H., Muramatsu T.: Stimulation of collagen expression and glycosaminoglycan synthesis by midkine in human skin fibroblasts. Arch. Dermatol. Res., 1997; 289: 429-433
106. Yasuhara O., Muramatsu H., Kim S.U., Muramatsu T., Maruta H., McGeer P.L.: Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. Biochem. Biophys. Res. Commun., 1993; 192: 246-251
107. Yasuhara O., Schwab C., Matsuo A., Kim S.U., Steele J.C., Akiguchi I., Kimura J., McGeer E.G., McGeer P.L.: Midkine-like immunoreactivity in extracellular neurofibrillary tangles in brains of patients with parkinsonism-dementia complex of Guam. Neurosci. Lett., 1996; 205: 107-110
108. Yoshida Y., Goto M., Tsutsui J., Ozawa M., Sato E., Osame M., Muramatsu T.: Midkine is present in the early stage of cerebral infarct. Dev. Brain Res., 1995; 85: 25-30
109. Yoshida Y., Ikematsu S., Moritoyo T., Goto M., Tsutsui J., Sakuma S., Osame M., Muramastu T.: Intraventricular administration of the neurotrophic factor midkine ameliorates hippocampal delayed neuronal death following transient forebrain ischemia in gerbils. Brain Res., 2001; 894: 46-55
110. Yu G.S., Hu J., Nakagawa H.: Inhibition of b-amyloid cytotoxicity by midkine. Neurosci. Lett., 1998; 254: 125-128
111. Yu J.L., Rak J.W.: Host microenvironment in breast cancer development: inflammatory and immune cells in tumor angiogenesis and arteriogenesis. Breast Cancer Res., 2003; 5: 83-88
112. Zhou H., Muramatsu T., Halfter W., Tsim K.W., Peng H.B.: A role of midkine in the development of the neuromuscular junction. Mol. Cell Neurosci., 1997; 10: 56-70
113. Zou K., Muramatsu H., Ikematsu S., Sakuma S., Salama R.H., Shinomura T., Kimata K., Muramatsu T.: A heparin-binding growth factor, midkine, binds to a chondroitin sulfate proteoglycan, PG-M/versican. Eur. J. Biochem., 2000; 267: 4046-4053
114. Zou P., Zou K., Muramatsu H., Ichihara-Tanaka K., Habuchi O., Ohtake S., Ikematsu S., Sakuma S., Muramatsu T.: Glycosaminoglycan structures required for strong binding to midkine, a heparin binding growth factor. Glycobiology, 2003; 13: 35-42